Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial

References

• Commonwealth of Australia.. Review of Methadone Treatment in Australia—Final Report. Canberra, National Illicit Drug Strategy. 1995
   Google Scholar
• Lintzeris N, Koutroulis G, Rogers P, et al, Report on the Evaluation of Community Methadone Services in Victoria. Fitzroy, Victoria, Turning Point Alcohol & Drug Centre. 1996
   Google Scholar
• Ritter A, Kutin J, Lintzeris N, Bammer G. New Pharmacotherapies Project Feasibility: Report Expanding Treatment Options for Heroin Dependence in Victoria: Buprenorphine, LAAM, Naltrexone and Slow-release Oral Morphine. Fitzroy, Turning Point;. 1997
   Google Scholar
• Lintzeris N, Bammer G, Rushworth L, Jolley D, Whelan G.. Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom triggered dose titration study. Drug Alcohol Depend. 2003; 70: 287–294. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lintzeris N.. Buprenorphine dosing regimes in the management of outpatient heroin withdrawal. Drug Alcohol Rev. 2002; 21: 39–45. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Bell J, Bammer G, Jolley D, Rushworth L.. A randomised controlled trial of buprenorphine in the ambulatory management of heroin withdrawal. Addiction. 2002; 97: 1395–1404. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N.. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Med J Aust. 2003; 179: 38–42. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Department of Health and Community Services.. Victorian Methadone Program: Guidelines for Providers. Melbourne, Victorian Government Department of Health and Community Services. 1995
   Google Scholar
• Darke S, Hall W, Wodak A, et al, Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Addiction. 1992; 87: 733–742
   Web of Science ®Google Scholar
• Ritter A, Lintzeris N, Clark N, Panjari M, Kutin J, Bammer G. The Buprenorphine Implementation Trial: Final Report. FitzroyAustralia, Turning Point Alcohol and Drug Centre;. 2001
   Google Scholar
• Lintzeris N, Ritter A, Dunlop A, Muhleisen P.. Training primary health care professionals to provide buprenorphine and LAAM treatment. Subst Abuse. 2002; 23: 245–254. [CROSSREF]
   PubMedGoogle Scholar
• Strain EC, Stitzer ML, Liebson IA, Bigelow GE.. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol. 1996; 16: 58–67. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mattick RP, Ali R, White JM, O'Brien S, Wolk S, Danz C.. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction. 2003; 98: 441–452. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• National Drug Strategy.. National Buprenorphine Policy. Canberra, Commonwealth of Australia. 2002, Available at:. www.nationaldrugstrategy.gov.au
   Google Scholar
• Lintzeris N, Clark N, Muhleisen P, et al, National Clinical Guidelines on the Use of Buprenorphine in the Management of Opiate Dependence. Canberra, National Drug Strategy, Commonwealth Department of Health and Aged Care. 2001, Available at. www.nationaldrugstrategy.gov.au/resources/publist.htm
   Google Scholar
• Illicit Drug Reporting System. Drug Trends Bulletin, December 2003.. Sydney, National Drug and Alcohol Research Centre. 2003
   Google Scholar
• Lloyd Jones M, Frei M, Dunlop A, et al, Buprenorphine injecting in Melbourne. Paper presented at Annual Conference, Australian Professional Society Alcohol and other Drugs, Adelaide. 2002
   Google Scholar
• Muhleisen P, Panjari M, Lee N.. Buprenorphine dispensing in a cohort of community pharmacies in Victoria. Australian Pharmacist. 2003; 22(3)229–234
   Google Scholar
• Allsop S, Corry A, Ernst L, et al, National Learning Objectives and Assessment Procedures for the Pharmacological Management of Opioid Dependence. Canberra, Commonwealth Department of Health and Aged Care, in press.
   Google Scholar
• Department of Health and Community Services.. Substitution Treatment Programs, Victoria: Drugs of Dependence Unit Report. Melbourne, Victorian Government Department of Health and Community Services. 2003
   Google Scholar
• Vignau J.. Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine. Eur Addict Res. 1998; 4: 29–31. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lee N, Lintzeris N, Ritter R.. PSI Project Preliminary Report: psychosocial interventions for clients in substitution maintenance treatment. Fitzroy, Victoria, Turning Point Alcohol & Drug Centre. 2002
   Google Scholar